The FDA has now started a review of the highly anticipated drug, and AZ is using a priority review voucher to shorten the ...

The FDA estimates that a typical nonclinical programme with a monoclonal antibody product could include more than 100 NHPs, ...

VTx-002 is described as a first-in-class vectorised antibody targeting molecular pathways involving TAR DNA-binding protein ...

Consistency is another. HCPs are increasingly accustomed to seamless digital experiences in other areas of their professional ...

Bender discusses the possibility of shifting the oncological treatment paradigm with intra-tumourally injected therapeutics, ...

The federal appeals court has now reversed the 2022 verdict upholding the '039 patent, thereby vacating the Texas court's ...

Bayer has started a phase 3 trial of its intrauterine contraceptive Mirena in an endometrial condition that can lead to ...

DTC pharma is America’s newest care pathway. TrumpRx has exposed the vacuum surrounding it.

Johnson & Johnson's Imaavy has become the first FcRn blocker to be approved in the EU as a treatment for both adolescent and ...

Successful AI implementation ultimately depends on how well these technologies align with the realities of clinical practice.

The drive to roll out AI comes after sweeping job losses at the FDA that resulted from the cost-cutting drive implemented by ...

Long-serving FDA figure Richard Pazdur has filed papers to retire, shortly after being appointed to lead the agency's Center ...